Floatz logo

Arachidyl Amido Cholanoic Acid

Cholelithiasis

Galmed Pharmaceuticals LtdSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Cholelithiasis cohort.

Asset / SponsorPhaseRating
Hepatitis B Virus Vaccine
Eunice Dube
Phase 4BB
Gardasil 9 Vaccine
Eunice Dube
Phase 4BB
Ketorolac
Hamilton Health Sciences Corporation
Phase 3B
Obeticholic Acid
Sahlgrenska University Hospital
Phase 2CCC
Indocyanine Green
Intuitive Surgical
N/AD
Lignocaine
Universiti Kebangsaan Malaysia Medical Centre
N/ANR

Same molecule, other indications

Arachidyl Amido Cholanoic Acid is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
BB
Indicative · Phase 3
68 / 100
View asset →
liver disorderDormant
B
Indicative · Phase 2
57 / 100
View asset →
fatty liver diseaseDormant
B
Indicative · Phase 2
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →